Skip to content
Application 203231
- Type
- NDA
- Sponsor
- INFORLIFE
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 4MG BASE/100ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |
| 25021-826 | zoledronic acid | zoledronic acid | Sagent Pharmaceuticals | NDA | Current |